Weight loss injections such as Mounjaro, Wegovy and Ozempic have helped many people lose a significant amount of weight. But these are treatments for a long-term condition, not a short course of tablets — and one of the most common questions people ask is what happens if, or when, they stop. Do the results last? Will the weight pile back on? And what about the loose skin and facial changes people describe online? This is an educational guide to the evidence, written to help you understand the realities and have a better-informed conversation with a qualified prescriber.
Are weight loss injections meant to be forever?
Obesity is increasingly understood by clinicians as a chronic, relapsing condition rather than a temporary problem to be fixed and forgotten. GLP-1 medications work by quietening appetite and slowing how quickly the stomach empties for as long as you take them. They manage the condition; they do not cure it. That framing matters, because it explains why stopping is rarely as simple as many people hope.
Whether to start, continue, taper or stop a prescription-only medicine is a medical decision that belongs with the prescriber who is monitoring you — never something to change abruptly on your own, and never a reason to buy top-up supplies from unregulated online sellers, where counterfeit products are a genuine risk. What follows is background to inform that conversation, not medical advice.
What the evidence says about stopping
The research picture has become clearer and, for many, sobering. The most comprehensive analysis to date — a 2026 review pooling 37 trials and more than 9,000 participants — found that people who stop GLP-1 medication tend to regain weight around four times faster than people who stop a diet-based programme, at an average of roughly 0.8 kg a month. On average, about 60% of the weight lost returns within the first year, and most people drift back towards their pre-treatment weight within around 18 months.
Individual trials tell the same story. In a study of tirzepatide, people who had lost about a fifth of their body weight and then switched to a placebo regained a substantial share of it, while those who continued treatment held on to their results and lost a little more. In a semaglutide study, participants who stopped regained roughly two-thirds of their lost weight within a year — and the improvements in blood pressure, blood sugar and cholesterol that had come with weight loss drifted back towards where they started too. The benefits, in other words, are tied to the treatment.
Regaining weight after stopping is not a failure of willpower — it is predictable biology. The medication was suppressing a set-point the body defends, and once it is gone, that set-point reasserts itself.
Why the weight tends to return
When the medication is withdrawn, its effects fade quickly. The appetite-suppressing signal drops away within days, the stomach empties at its old, faster rate, and hunger can rebound to — or even above — its previous level. Calorie intake creeps up, often without any conscious decision, and the body’s “defended” weight set-point, which the drug had been holding down, gradually reasserts itself.
Doctors often compare this to stopping medication for blood pressure or cholesterol: the numbers rise again because the underlying tendency was being managed, not removed. The same principle applies here, which is why so many clinicians now talk about long-term management rather than a fixed course.
The fuller picture — it is not inevitable
It would be misleading to suggest everyone regains everything. A large real-world analysis of nearly 8,000 patients found a more encouraging pattern than the trials alone: many people who came off treatment did not see major regain, because they restarted later, switched to a different medication, or successfully embedded new eating and activity habits. Outcomes vary enormously and depend heavily on what happens next.
Encouragingly, researchers at Cambridge found that although regain is common in the first year, it tends to plateau — with people typically keeping off around a quarter of the weight they had lost, long term. Stopping is not a straight line back to square one.
Coming off more gradually
If and when stopping is on the table, the evidence points to a planned, supported approach rather than an abrupt halt. Strategies your prescriber may discuss include:
- A gradual dose taper rather than stopping suddenly, giving appetite time to adjust.
- Resistance (strength) training, ideally begun during treatment, to preserve muscle — rapid weight loss can strip muscle as well as fat, which lowers metabolism and makes regain easier.
- Structured eating and self-monitoring, such as tracking portions and protein, kept up after the medication stops.
- Behavioural support — coaching, therapy or group accountability.
- Switching or continuing rather than stopping, where clinically appropriate; NICE currently allows use for up to around two years within specialist services, and maintenance approaches are still evolving.
In the NHS, GLP-1 prescriptions come with wraparound dietary and lifestyle support as a condition of treatment — a recognition that the medication works best as one part of a broader plan, not a standalone fix. If you are still early in your journey, our guide to what to expect in the first 12 weeks sets out how progress typically unfolds.
“Ozempic face” and loose skin
Alongside regain, the other much-discussed consequence of GLP-1 weight loss is its effect on skin. “Ozempic face” is a media term for the gaunt, hollowed or aged appearance some people notice after significant weight loss — sunken cheeks, hollowing around the eyes, jowling, a softer jawline and a more crepey neck.
The key point is that this is not a side effect of the drug itself. It is a consequence of losing fat quickly. The face holds several distinct fat pads that deflate as you slim down, and when that happens fast, the skin cannot retract to keep pace. The same changes follow any rapid, large weight loss, including after bariatric surgery. Because these medications can drive fast loss, they make the effect more visible — but the cause is the speed and scale of fat loss, not the pharmacology.
The same mechanism can leave loose skin on the body — most commonly a fold over the lower abdomen, but also on the inner thighs, upper arms, chest and buttocks. You are more likely to notice it if you lose a large proportion of your weight (roughly 15–20% or more), if you are older, if your skin has significant sun damage, or if protein intake has been low. Skin quality and genetics play a big part, so two people losing the same weight can end up looking quite different.
Will it settle on its own? Mild laxity often improves over 12–18 months as skin gradually remodels, particularly in younger people with good elasticity. But it is worth being honest: true excess skin that hangs in folds is no longer fat, and it cannot be exercised, massaged or creamed away. Once skin has lost its structural integrity, physical removal is the only definitive fix.
What can help
For milder changes, a range of non-surgical clinic treatments aim to support skin quality and restore lost volume — radiofrequency and ultrasound-based tightening, collagen-stimulating biostimulators, microneedling, and dermal fillers to replace facial volume (results from fillers are temporary, typically lasting several months to a year or so). Building muscle through resistance training can also improve appearance by adding shape beneath the skin. None of these performs miracles, and a good practitioner will be candid about their limits for advanced sagging. Our guide to non-surgical anti-ageing treatments explains these options in more depth.
For moderate to severe loose skin — an abdominal apron, significant arm or thigh laxity, or a heavily aged neck — surgery such as a tummy tuck, arm or thigh lift, or a neck or face lift is the only route to a definitive result. These are major procedures with real risks and recovery, and reputable surgeons will usually ask you to be at a stable weight for several months first. If that is your situation, the right next step is a consultation with a suitably qualified surgeon.
Making an informed choice
The honest summary is this: for most people, weight loss injections work while you take them, and the effect fades when you stop. That is not so much a flaw as the nature of treating a chronic condition — and, crucially, it does not mean stopping is doomed. A planned taper, muscle-preserving exercise, sustained lifestyle changes and ongoing medical support can all tilt the odds in your favour, and even those who regain some weight tend to keep a meaningful amount off.
If you are thinking about starting, continuing or stopping, the single most valuable thing you can do is have that conversation with a properly regulated prescriber who knows your history. To learn more, our guides to what Mounjaro (tirzepatide) is and whether weight loss injections are safe are good places to continue.
Use Clinic Finder to compare accredited clinics near you and check that any prescriber or aesthetic practitioner you consider is properly qualified and regulated before you commit.
